Brazil vs Malawi: HIV/AIDS deaths averted by antiretroviral therapy
Brazil
49,655 deaths
in 2024
Malawi
53,389 deaths
in 2024
Brazil rank
10th
Malawi rank
9th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Brazil
- Malawi
How they compare
Malawi currently reports 53,389 deaths against 49,655 deaths in Brazil, a difference of 3,734 deaths.
That makes Malawi's figure about 1.1 times Brazil's.
The two have swapped places 2 times across 35 shared years of data; in 1990 it was Malawi ahead.
Brazil ranks 10th and Malawi ranks 9th of 157 countries.
Across the 4 decades both report, Brazil averaged higher in 2 and Malawi in 2.
Head to head by decade
| Decade | Brazil | Malawi | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 4,547 deaths | 0 deaths | 4,547 deaths | Brazil |
| 2000s | 15,777 deaths | 9,707 deaths | 6,070 deaths | Brazil |
| 2010s | 28,138 deaths | 46,122 deaths | 17,983 deaths | Malawi |
| 2020s | 47,798 deaths | 53,202 deaths | 5,404 deaths | Malawi |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Brazil or Malawi?
- Malawi, at 53,389 deaths against 49,655 deaths in Brazil as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Brazil and Malawi?
- 3,734 deaths, with Malawi ahead.
- How many years of comparable data are there for Brazil and Malawi?
- 35 years are reported by both, from 1990 to 2024.
- How do Brazil and Malawi rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Brazil ranks 10th and Malawi ranks 9th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.